drugset / Trial / NCT00808288
A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the effects and safety of PF-00610355 on patients with chronic obstructive lung disease (COPD)
Timeline
- Start
- 2010-03
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-00610355 | Small molecule | 100 ug | Oral |
| Subject | PF-00610355 | Small molecule | 300 ug | Oral |
| Subject | PF-00610355 | Small molecule | 600 ug | Oral |
| Comparator | Salmeterol | Other / unclassified | 50 ug | — |